Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel compounds with dual S1P receptor agonist and histamine H3 receptor antagonist activities act protective in a mouse model of multiple sclerosis
Faik Imeri, Bisera Stepanovska Tanturovska, Aleksandra Živković, et al.
Neuropharmacology (2021) Vol. 186, pp. 108464-108464
Open Access | Times Cited: 21

Showing 21 citing articles:

Progress in the Application of Drugs for the Treatment of Multiple Sclerosis
Weipeng Wei, Denglei Ma, Lin Li, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 41
Neuronal activity and remyelination: new insights into the molecular mechanisms and therapeutic advancements
Yiting Zhou, Jing Zhang
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 14
Exploring the Role of Neurotransmitters in Multiple Sclerosis: An Expanded Review
Enes Akyüz, Betul Rana Celik, Feyza Şule Aslan, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 4, pp. 527-553
Closed Access | Times Cited: 13
Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties
Katarzyna Szczepańska, Sabina Podlewska, Maria Dichiara, et al.
ACS Chemical Neuroscience (2021) Vol. 13, Iss. 1, pp. 1-15
Open Access | Times Cited: 31
Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain
Katarzyna Szczepańska, Tadeusz Karcz, Maria Dichiara, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9658-9683
Open Access | Times Cited: 11
Emerging therapeutic application of clemastine: a review of recent patents updates
Simran Soni, Ginpreet Kaur
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
S1P/S1PR signaling pathway advancements in autoimmune diseases
Jianbin Li, Yiping Huang, Yueqin Zhang, et al.
Biomolecules and Biomedicine (2023)
Open Access | Times Cited: 10
Pharmacological Effects of FTY720 and its Derivatives
Mengyuan Han, Xiangran Liu, Sendaer Hailati, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 3, pp. 192-200
Closed Access | Times Cited: 3
Inhibiting sphingosine 1-phosphate lyase: From efficacy to mechanism
Nelson George, Junhua Xiao
Neurobiology of Disease (2024) Vol. 199, pp. 106585-106585
Open Access | Times Cited: 3
Pharmacological treatment promoting remyelination enhances motor function after internal capsule demyelination in mice
Reiji Yamazaki, Yasuyuki Osanai, Tom Kouki, et al.
Neurochemistry International (2023) Vol. 164, pp. 105505-105505
Open Access | Times Cited: 8
Insight into modulators of sphingosine-1-phosphate receptor and implications for cardiovascular therapeutics
Yuxin Xie, Hui Yao, Jin-Fu Peng, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 3, pp. 300-310
Closed Access | Times Cited: 2
Sphingosine 1-Phosphate Lyase in the Developing and Injured Nervous System: a Dichotomy?
Junhua Xiao
Molecular Neurobiology (2023) Vol. 60, Iss. 12, pp. 6869-6882
Open Access | Times Cited: 6
The Current Landscape in the Development of Small-molecule Modulators Targeting Sphingosine-1-phosphate Receptors to Treat Neurodegenerative Diseases
Sidhartha S. Kar, Soumya Ranjan Gharai, Sujit K. Sahu, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 28, pp. 2431-2446
Closed Access | Times Cited: 1
Sphk1 and Sphk2 Differentially Regulate Erythropoietin Synthesis in Mouse Renal Interstitial Fibroblast-like Cells
Redona Hafizi, Faik Imeri, Bisera Stepanovska Tanturovska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 5882-5882
Open Access | Times Cited: 7
ST-2191, an Anellated Bismorpholino Derivative of Oxy-Fingolimod, Shows Selective S1P1 Agonist and Functional Antagonist Potency In Vitro and In Vivo
Bisera Stepanovska Tanturovska, Aleksandra Živković, Faik Imeri, et al.
Molecules (2021) Vol. 26, Iss. 17, pp. 5134-5134
Open Access | Times Cited: 7
The Histamine and Multiple Sclerosis Alliance: Pleiotropic Actions and Functional Validation
Cinzia Volonté, Savina Apolloni, Susanna Amadio
Current topics in behavioral neurosciences (2021), pp. 217-239
Closed Access | Times Cited: 6
Histamine receptors in GtoPdb v.2023.1
Paul L. Chazot, Marlon Cowart, Hiroyuki Fukui, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 2
Deciphering the role of sphingosine 1‐phosphate in central nervous system myelination and repair
Fatima Binish, Junhua Xiao
Journal of Neurochemistry (2024)
Open Access
Histamine H 3 receptor antagonists/inverse agonists: a patent review (October 2017- December 2023) documenting progress
Dorota Łażewska, Katarzyna Kieć‐Kononowicz
Expert Opinion on Therapeutic Patents (2024), pp. 1-25
Open Access
Synthesis and anticancer profile of novel FTY720 analogues with azobenzene frameworks
Simona Fazekašová, Jozef Gonda, Miroslava Martinková, et al.
Tetrahedron (2023) Vol. 137, pp. 133391-133391
Closed Access | Times Cited: 1
Anemoside B4 ameliorates experimental autoimmune encephalomyelitis in mice by modulating inflammatory responses and the gut microbiota
Min Zou, Fangjun Chen, Li-rong Deng, et al.
European Journal of Pharmacology (2022) Vol. 931, pp. 175185-175185
Closed Access | Times Cited: 2
Page 1

Scroll to top